Mindray Announced a Settlement Agreement with Beckman Coulter Inc
SHENZHEN, China, Nov. 12, 2013 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced a settlement agreement with Beckman Coulter Inc. On November 11, 2013, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a subsidiary of Mindray, entered into a settlement agreement related to an ordinary course commercial dispute with an OEM manufacturing customer, Beckman Coulter Inc. In connection with this settlement, Mindray will take a litigation related charge of approximately $15 million in the fourth quarter of 2013.
The commercial dispute did not involve intellectual property or product liability matters, and Mindray has determined that the related termination of the OEM arrangement is not material to its business or operations.
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.
For investor and media inquiries please contact:
Mindray Medical International Limited
In the U.S:
Western Bridge, LLC
SOURCE Mindray Medical International Limited
More by this Source
Mindray Announces ADS Dividend Record Date for March 2014 Dividend
Mar 07, 2014, 06:00 ET
BeneHeart R12 - La nouvelle solution de Mindray pour les ECG avancés
Mar 03, 2014, 22:21 ET
BeneHeart R12 -- neue, moderne EKG-Lösung von Mindray
Mar 03, 2014, 19:31 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.